Position in HIMS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,309,935
+$614,753 QoQ
Shares Held
63,099
+194.7% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GUGGENHEIM CAPITAL LLC holds $73,564,946 across 16 Drug Manufacturers - Specialty & Generic names. HIMS ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
361,944 | $42,785,398 | |
| 2 | VTRS |
Viatris Inc
|
681,711 | $9,209,914 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,720 | $5,763,765 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
38,866 | $5,120,206 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
79,787 | $2,403,183 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
62,931 | $1,505,938 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
This page
|
63,099 | $1,309,935 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
94,309 | $1,306,179 |
All Filings in HIMS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,309,935 | 63,099 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $695,182 | 21,410 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,449,025 | 25,547 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,257,516 | 25,226 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $832,157 | 28,161 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $274,007 | 11,332 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||